Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 4 5Phase NA 3Phase 3 3Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3

Interventions

Docetaxel 77Radiotherapy 73Prednisone 66Leuprolide 51Goserelin 49Gemcitabine 49Cisplatin 48bicalutamide 46enzalutamide 43Androgen Antagonists 36pembrolizumab 32Abiraterone Acetate 31Mitomycin 29acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 28Magnetic Resonance Spectroscopy 28Carboplatin 27Flutamide 25Nivolumab 24Triptorelin Pamoate 23Sunitinib 23apalutamide 22Radiation 22Doxorubicin 20darolutamide 19abiraterone 18Gonadotropin-Releasing Hormone 18cabozantinib 17atezolizumab 16Specimen Handling 16Radiosurgery 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Dutasteride × Genitourinary × Clear all
NCT00780754 2018-03-06

Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia

Kaunas University of Medicine

Phase 3 Completed
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT00056407 2016-09-23

REDUCE

GlaxoSmithKline

Phase 3 Completed
8,231 enrolled 34 charts
Genitourinary

Prostatic Neoplasms

NCT00398281 2014-01-10

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Completed
450 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡